Combination of nanoparticles with physical stimuli toward cancer therapy

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Targeted drug delivery is crucial for effective and safe cancer treatment.
• Nanoparticles are widely used for delivering anticancer drugs (small molecules, proteins, nucleic acids) to cancer cells and immunocompetent cells.
• Current nanoparticle systems, like PEGylated nanoparticles, face limitations such as the 'PEG dilemma,' hindering cellular uptake despite accumulation in tumors.

Purpose of the Study:

• To review strategies for improving nanoparticle-mediated drug delivery in cancer therapy.
• To focus on combining nanoparticles with physical stimuli to overcome current limitations.
• To enhance targeted delivery and cellular uptake of anticancer therapeutics.

Main Methods:

• Review of existing literature on nanoparticle drug delivery systems for cancer.
• Analysis of strategies to improve nanoparticle efficacy, including receptor-mediated targeting.
• Focus on the integration of physical stimuli (electric pulse, ultrasound) with nanoparticle systems.

Main Results:

• Nanoparticles accumulate in cancerous tissues, but surface modifications like PEGylation can impede cellular uptake.
• Additional targeting strategies are necessary to enhance nanoparticle delivery and cellular internalization.
• Combining nanoparticles with physical stimuli presents a promising approach to overcome delivery barriers.

Conclusions:

• The efficacy of current nanoparticle-based cancer drug delivery systems is often insufficient.
• Overcoming the 'PEG dilemma' and improving cellular uptake are key challenges in nanoparticle therapy.
• Physical stimuli offer a viable strategy to enhance the targeted delivery and therapeutic potential of nanoparticles in cancer treatment.